Osteosarcoma is the most common primary bone malignant tumor in children and adolescents. It is characterized by strong aggressiveness, poor predictability, and high mortality and disability rate[1,2]。 Radiation is one of the main methods of osteosarcoma treatment at present, which can effectively treat metastatic bone pain and those with recurrent bone pain, who are not suitable for surgery or refuse surgery. However, radiation resistance is the main bottleneck of radiation, and how to improve radiosensitivity is the main problem in the treatment of osteosarcoma. microRNAs (miRNAs) are a class of endogenous non-coding single-stranded RNA molecules, which play an important role in regulating cell growth, differentiation, proliferation, apoptosis and tumorigenesis[3]。 Related studies have shown that miRNAs can also inhibit the activation of signal transduction pathways related to target genes, increase the apoptosis rate and reduce tumor radiation resistance, and have the potential to become a new target to target and improve the radiosensitivity of osteosarcoma.